4//SEC Filing
NxStage Medical, Inc. 4
Accession 0001209191-13-031852
CIK 0001333170operating
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:36 PM ET
Size
5.2 KB
Accession
0001209191-13-031852
Insider Transaction Report
Form 4
Shea Thomas
SVP Manufacturing Operations
Transactions
- Sale
Common Stock
2013-06-10$13.73/sh−5,000$68,629→ 15,071 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2012.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.58 to $13.84. The reporting person undertakes to provide to the issuer, any holder of the issuer's stock, or the SEC, upon request, full information regarding the number of shares sold at each separate price within the range described above.
Documents
Issuer
NxStage Medical, Inc.
CIK 0001333170
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001333170
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:36 PM ET
- Size
- 5.2 KB